Emmanuel Ifeanyi Obeagu Department of Biomedical and Laboratory Science, Africa University, Zimbabwe Sickle cell disease (SCD) and HIV are chronic conditions with overlapping pathophysiological mechanisms that can significantly impact patient outcomes. Vaso-occlusive crises (VOCs), a hallmark of SCD, result from Read More …
Tag: HIV
Gene Therapy Prospects for HIV and Sickle Cell Disease Co-Morbidity
Emmanuel Ifeanyi Obeagu Department of Biomedical and Laboratory Science, Africa University, Zimbabwe The co-morbidity of human immunodeficiency virus (HIV) and sickle cell disease (SCD) presents unique clinical challenges, necessitating innovative therapeutic approaches to improve patient outcomes. Gene therapy has emerged Read More …
